Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroids or clobazam for ESES syndrome
2013-000531-27Phase 4Terminated
- Sponsor
- University Medical Center Utrecht
- Start
- Jan 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in developmental and epileptic encephalopathy with spike wave activation in sleep (DEE-SWAS) and epilepsy comparing Clobazam arm with Corticosteroid arm (2 arms). Primary endpoint: Intelligence quotient or developmental quotient. Started Jan 2014; status: terminated.
02
Drugs
clobazamprednisolonemethylprednisolone
03
Conditions
developmental and epileptic encephalopathy with spike wave activation in sleep (DEE-SWAS)epilepsy
Beyond the preview
Go deeper on 2013-000531-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000531-27.